Screener
Zevra Therapeutics, Inc. ZVRA PP&E (Net)
PP&E (Net) at other companies
Segments
By geography
Other financials
Where this comes from
Reported directly by Zevra Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The source filing: Zevra Therapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:19 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001434647-26-000068
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Total current assets | 251,302 | 223,007 |
| Investments, noncurrent | 38,609 | 47,879 |
| Inventories, noncurrent | — | 879 |
| Property and equipment, net | 641 | 489 |
| Operating lease right-of-use assets | 1,667 | 1,212 |
| Goodwill | 4,701 | 4,701 |
| Intangible assets, net | 5,789 | 6,421 |
| Other long-term assets | 3 | 143 |
ITEM 1.FINANCIAL STATEMENTS
FAQ
- What is Zevra Therapeutics, Inc.'s PP&E (net)?
- Zevra Therapeutics, Inc. (ZVRA) reported PP&E (net) of $641K in Q2 2026.
- How has Zevra Therapeutics, Inc.'s PP&E (net) changed year-over-year?
- Zevra Therapeutics, Inc.'s PP&E (net) increased by 7.0% year-over-year, from $599K to $641K.
- What is the long-term trend for Zevra Therapeutics, Inc.'s PP&E (net)?
- Over 5 years (2020 to 2025), Zevra Therapeutics, Inc.'s PP&E (net) has grown at a -14.0% compound annual growth rate (CAGR), from $1.04M to $489K.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.
Ask your AI about Zevra Therapeutics, Inc.'s pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude